2 days Ago By ABMN Staff
Russell Investments Group Ltd. trimmed its holdings in shares of InfuSystem Holdings, Inc. ( NYSE:INFU – Free Report ) by 13.
8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 387,014 shares of the company’s stock after selling 62,109 shares during the quarter. Russell Investments Group Ltd.
owned 1.82% of InfuSystem worth $3,270,000 at the end of the most recent reporting period. A number of other institutional investors have also recently made changes to their positions in INFU.
BNP Paribas Financial Markets lifted its position in InfuSystem by 66.4% in the third quarter. BNP Paribas Financial Markets now owns 4,076 shares of the company’s stock worth $27,000 after buying an additional 1,626 shares during the last quarter.
State Street Corp grew its holdings in InfuSystem by 1.1% during the 3rd quarter. State Street Corp now owns 267,012 shares of the company’s stock valued at $1,789,000 after purchasing an additional 3,019 shares during the last quarter.
Barclays PLC raised its position in InfuSystem by 300.5% in the 3rd quarter. Barclays PLC now owns 28,597 shares of the company’s stock worth $192,000 after purchasing an additional 21,457 shares during the period.
Geode Capital Management LLC lifted its stake in InfuSystem by 1.8% in the third quarter. Geode Capital Management LLC now owns 436,508 shares of the company’s stock worth $2,925,000 after purchasing an additional 7,550 shares during the last quarter.
Finally, JPMorgan Chase & Co. boosted its position in shares of InfuSystem by 74.1% during the third quarter.
JPMorgan Chase & Co. now owns 15,556 shares of the company’s stock valued at $104,000 after buying an additional 6,623 shares during the period. Institutional investors own 71.
13% of the company’s stock. InfuSystem Stock Performance InfuSystem stock opened at $4.98 on Thursday.
The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.59 and a current ratio of 1.
98. The company has a market capitalization of $104.66 million, a PE ratio of 83.
01 and a beta of 1.90. The company has a 50 day moving average price of $6.
30 and a 200-day moving average price of $7.37. InfuSystem Holdings, Inc.
has a fifty-two week low of $4.61 and a fifty-two week high of $9.97.
Wall Street Analyst Weigh In Read Our Latest Report on INFU InfuSystem Company Profile ( Free Report ) InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.
See Also Want to see what other hedge funds are holding INFU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InfuSystem Holdings, Inc. ( NYSE:INFU – Free Report ).
Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter ..
_0.jpg?itok=yAIF6nFK)
